Exploring New Horizons: Innovative Approaches in Pancreatic Cancer Treatment
In September 2007, Sheila Sky Kasselman received life-altering news—a small tumor was discovered at the head of her pancreas. This diagnosis followed an arduous ten-month journey marked by anxiety, weight loss, and unexpected health changes, including temporary diabetes and gallbladder issues. Despite initial misdiagnoses, it was a collapsed bile duct and subsequent jaundice that finally led to the identification of pancreatic adenocarcinoma.
The Path to Diagnosis and Treatment
Sheila’s medical team at Henry Ford Health System in Detroit acted swiftly upon her diagnosis. Given that her tumor was still small and localized, it was classified as stage Ia. Sheila underwent a rigorous treatment regimen that included six weeks of chemotherapy with Xeloda (capecitabine) and radiation, under the expert guidance of Dr. Kenneth Levin. In January 2008, she had a Whipple procedure performed by Dr. Vic Velonavich, with no further chemotherapy required post-surgery. Shortly after her operation, she began testing for the BRCA gene and plans to pursue further genetic evaluations at the University of Michigan.
Becoming a Voice for Pancreatic Cancer Awareness
As Sheila gained strength from her recovery, she channeled her experience into activism by founding the Sky Foundation in June 2008. Despite having no prior nonprofit experience, her passion drove the organization to grow significantly within the Detroit area. The foundation focuses on raising awareness and funding groundbreaking research to combat this formidable disease.
Sheila now dedicates her time to multiple boards, committees, and a young professionals’ group (YPG). Among their notable initiatives are a Women’s Event in May aimed at educating women about pancreatic cancer and an annual fundraising luncheon held in November at the MGM Grand Hotel in Detroit. This year, the YPG is also participating as Team Sky in a marathon.
Celebrating Survival and Hope
This September marks a significant milestone for Sheila as she celebrates 10 years as a survivor. At 77 years old, she reflects on her journey with gratitude, emphasizing that every day offers both challenges and opportunities for celebration. Her mission remains clear: to save lives and instill hope in those affected by pancreatic cancer.
Sheila’s commitment to raising awareness and supporting research has made a profound impact. Sadly, she passed away from complications related to pancreatic cancer 16 years following her diagnosis. Her legacy lives on through the Sky Foundation and the countless lives she touched.
To hear more about Sheila’s inspiring story, watch her feature in “I Didn’t Expect to Be Doing This.”
